Congratulations to Xiuqi “Michael” Wang on the successful defense of his dissertation entitled, “Discovery of Imidazopyridine Analogs as FLT3-ITD Secondary Mutant Inhibitors for the Treatment of Acute Myeloid Leukemia.” Dr. Wang was mentored by Dr. Hongyu Li and will be beginning a postdoctoral position in Dr. Jun Qi’s lab at the Dana-Farber Cancer Institute, Harvard Medical School.